• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Bullish Wednesday For Marijuana Stocks - Affinor Growers, Blueberries Medical Among Top Gainers

    6/26/24 4:30:05 PM ET
    $CARA
    $MXC
    $OGI
    $SNDL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Oil & Gas Production
    Energy
    Get the next $CARA alert in real time by email

    GAINERS:

    • Affinor Growers (OTC:RSSFF) shares closed up 78.57% at $0.10
    • Blueberries Medical (OTC:BBRRF) shares closed up 32.40% at $0.01
    • Charlottes Web Holdings (OTC:CWBHF) shares closed up 18.00% at $0.18
    • Pharmadrug (OTC:LMLLF) shares closed up 15.80% at $0.02
    • Global Hemp Group (OTC:GBHPF) shares closed up 14.00% at $0.03
    • Target Group (OTC:CBDY) shares closed up 13.64% at $0.00
    • Leafbuyer Techs (OTC:LBUY) shares closed up 10.69% at $0.02
    • Cannabix Technologies (OTC:BLOZF) shares closed up 8.80% at $0.34
    • Cresco Labs (OTC:CRLBF) shares closed up 7.59% at $1.70
    • iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 6.21% at $0.02
    • 22nd Century Group (NASDAQ:XXII) shares closed up 4.91% at $0.70
    • OrganiGram Holdings (NASDAQ:OGI) shares closed up 4.70% at $1.52
    • Tilray Brands (NASDAQ:TLRY) shares closed up 4.32% at $1.69
    • SNDL (NASDAQ:SNDL) shares closed up 3.80% at $1.91
    • C21 Investments (OTC:CXXIF) shares closed up 3.72% at $0.28
    • Mexco Energy (AMEX:MXC) shares closed up 3.35% at $11.72
    • Village Farms Intl (NASDAQ:VFF) shares closed up 3.02% at $0.99

    LOSERS:

    • Cara Therapeutics (NASDAQ:CARA) shares closed down 14.70% at $0.29
    • MJ Holdings (OTC:MJNE) shares closed down 11.63% at $0.00
    • SOL Glb Inv (OTC:SOLCF) shares closed down 10.30% at $0.04
    • 1933 Industries (OTC:TGIFF) shares closed down 9.57% at $0.01
    • CLS Holdings USA (OTC:CLSH) shares closed down 8.73% at $0.05
    • Global Compliance (OTC:FUAPF) shares closed down 6.97% at $0.01
    • Kaya Holdings (OTC:KAYS) shares closed down 5.30% at $0.05
    • RIV Capital (OTC:CNPOF) shares closed down 4.95% at $0.10
    • 4Front Ventures (OTC:FFNTF) shares closed down 4.03% at $0.09
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed down 3.80% at $0.01

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $CARA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CARA
    $MXC
    $OGI
    $SNDL

    CompanyDatePrice TargetRatingAnalyst
    Tilray Brands Inc.
    $TLRY
    4/3/2026$10.00Neutral → Buy
    Roth Capital
    Tilray Brands Inc.
    $TLRY
    4/2/2026$10.00Neutral → Buy
    Roth Capital
    Tilray Brands Inc.
    $TLRY
    1/27/2026Hold
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    SNDL Inc.
    $SNDL
    9/3/2025$5.00Buy
    Alliance Global Partners
    SNDL Inc.
    $SNDL
    7/17/2024Speculative Buy
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    7/17/2024Speculative Buy
    Canaccord Genuity
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$6.00 → $1.00Buy → Hold
    Stifel
    More analyst ratings

    $CARA
    $MXC
    $OGI
    $SNDL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tilray upgraded by Roth Capital with a new price target

    Roth Capital upgraded Tilray from Neutral to Buy and set a new price target of $10.00

    4/3/26 10:44:58 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray upgraded by Roth Capital with a new price target

    Roth Capital upgraded Tilray from Neutral to Buy and set a new price target of $10.00

    4/2/26 7:55:13 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $MXC
    $OGI
    $SNDL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $MXC
    $OGI
    $SNDL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Global General Counsel Gendel Mitchell exercised 93,928 shares at a strike of $0.58, covered exercise/tax liability with 49,782 shares and bought $3,496 worth of shares (6,000 units at $0.58), increasing direct ownership by 8% to 698,287 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:06:19 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    President and CEO Simon Irwin D bought $100,106 worth of shares (165,000 units at $0.61), increasing direct ownership by 4% to 3,941,633 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/30/25 6:52:32 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Financial Officer Merton Carl A bought $19,939 worth of shares (33,500 units at $0.60), increasing direct ownership by 4% to 798,069 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/30/25 3:12:46 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $MXC
    $OGI
    $SNDL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Holewinski David

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    4/8/26 4:20:07 PM ET
    $VFF

    SEC Form 4 filed by Henry John Patrick

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    4/8/26 4:14:44 PM ET
    $VFF

    SEC Form 4 filed by Ruffini Stephen C

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    4/2/26 6:01:54 PM ET
    $VFF

    $CARA
    $MXC
    $OGI
    $SNDL
    SEC Filings

    View All

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    4/15/26 7:50:19 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by SNDL Inc.

    6-K - SNDL Inc. (0001766600) (Filer)

    4/15/26 4:35:07 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 424B5 filed by Tilray Brands Inc.

    424B5 - Tilray Brands, Inc. (0001731348) (Filer)

    4/15/26 9:13:28 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $MXC
    $OGI
    $SNDL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SNDL to Report First Quarter 2026 Financial Results on April 29, 2026

    EDMONTON, Alberta, April 15, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) ("SNDL") announced today that it will release its first quarter 2026 financial results for the period ended March 31, 2026, before markets open on Wednesday, April 29, 2026. Following the release of its first quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on April 29, 2026. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/9eyekwcv  ABOUT SNDL INC. SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), through its wholly owned subsidiaries, is one of the largest vertically integrated cannabis com

    4/15/26 4:30:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously announced acquisition (the "Acquisition") of Sanity Group, pursuant to the terms of a share purchase agreement dated February 18, 2026 (the "Share Purchase Agreement"). In connection with closing of the Acquisition, a wholly owned subsidiary of the Company acquired all of the issued and outstanding shares of Sanity Group not already owned by the Company for an upfront purchase price paid on closing of €107.3 million, consisting of €78.0 million in cash and €29.3 million in share consideration (th

    4/15/26 12:03:00 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership

    NEW YORK and LEAMINGTON, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced a series of strategic initiatives marking its next phase of global growth, expanding its leadership across healthcare, cannabis and beverage while strengthening its ability to expand internationally and capture emerging market opportunities. Irwin D. Simon, Chairman and Chief Executive Officer, Tilray Brands, stated: "Tilray Brands is setting the pace for global innovation across healthcare, cannabi

    4/15/26 7:40:44 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $MXC
    $OGI
    $SNDL
    Leadership Updates

    Live Leadership Updates

    View All

    Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the resolution required to consummate the previously announced acquisition by the Company (the "Transaction") of Sanity Group GmbH ("Sanity Group") and the related private placement financing (the "Private Placement") with BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco ("BAT") at the Company's annual general and special meeting of shareholders (the "Shareholders") held on March 30, 2026 (the "Meeting"). Shareholders approved an ordinary resolution (the "Transaction Resolution") authorizing (i)

    3/30/26 8:30:00 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SNDL Announces Leadership Transition for Cannabis Segment

    EDMONTON, Alberta, March 30, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) ("SNDL" or the "Company") announced today that Tyler Robson, President of Cannabis, has left the Company in order to pursue other opportunities. Ryan Hellard, SNDL's current Chief Strategy Officer, will assume the role of Interim President of Cannabis. The Company wishes Mr. Robson success in his future endeavours. ABOUT SNDL INC. SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), through its wholly owned subsidiaries, is one of the largest vertically integrated cannabis companies and the largest private-sector liquor and cannabis retailer in Canada, with retail banners that include Ace Liquor, Wine and Beyond, Liquo

    3/30/26 5:00:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH

    ISS Cites Compelling Strategic Rationale, Favorable Market Reaction, and Strong Institutional Confidence in Recommending Shareholders Vote FOR the Transaction Resolution Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that Institutional Shareholder Services Inc. ("ISS"), a leading independent proxy advisory firm, has recommended that holders of common shares of Organigram ("Shareholders") vote FOR the ordinary resolution (the "Transaction Resolution") to approve the indirect acquisition of Sanity Group GmbH ("Sanity") at the Company's Annual General and Special Meeting of Shareholders (the "Mee

    3/23/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $MXC
    $OGI
    $SNDL
    Financials

    Live finance-specific insights

    View All

    SNDL to Report First Quarter 2026 Financial Results on April 29, 2026

    EDMONTON, Alberta, April 15, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) ("SNDL") announced today that it will release its first quarter 2026 financial results for the period ended March 31, 2026, before markets open on Wednesday, April 29, 2026. Following the release of its first quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on April 29, 2026. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/9eyekwcv  ABOUT SNDL INC. SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), through its wholly owned subsidiaries, is one of the largest vertically integrated cannabis com

    4/15/26 4:30:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results

    VLN® Commercial Expansion Drives Continued Shift Toward Higher Margin Proprietary Branded Products Expanding VLN® Store Counts and State Authorizations Increase Availability of Smoking Harm Reduction Products MOCKSVILLE, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced results for the fourth quarter and fiscal year-ended December 31, 2025, and provided an update on recent business highlights. The Company's proprietary low nicotine technology is designed to serve adult smokers who want to change their smoking habits by significantly reduci

    3/26/26 6:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026

    NEW YORK and LEAMINGTON, Ontario, March 25, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the Company will release its financial results for the third fiscal quarter which ended February 28, 2026, before the financial markets open on Wednesday, April 1, 2026. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 AM Eastern Time on the same day. The webcast can be accessed on the Events & Presentations section of Ti

    3/25/26 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $MXC
    $OGI
    $SNDL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    11/14/24 5:56:57 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care